PPA
AVNR

Parametric Portfolio Associates’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Parametric Portfolio Associates’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-34,192
Closed -$580K – 4091
2014
Q4 		$580K Sell
34,192
-11,107
-25% -$156K ﹤0.01% 3185
2014
Q3 		$540K Sell
45,299
-1,912
-4% -$13.1K ﹤0.01% 3153
2014
Q2 		$266K Buy
47,211
+3,998
+9% +$18.4K ﹤0.01% 3588
2014
Q1 		$159K Sell
43,213
-18
-0% -$69 ﹤0.01% 3675
2013
Q4 		$145K Buy
43,231
+415
+1% +$1.71K ﹤0.01% 3685
2013
Q3 		$181K Sell
42,816
-1,234
-3% -$5.85K ﹤0.01% 3628
2013
Q2 		$203K Buy
+44,050
New +$151K ﹤0.01% 3465

Parametric Portfolio Associates's AVNR Position: Q1 2015 in Review

Parametric Portfolio Associates sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 34,192 shares — an estimated $580K sold.

Parametric Portfolio Associates first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $580K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Parametric Portfolio Associates reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Parametric Portfolio Associates sold 34,192 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $580K.
  • Parametric Portfolio Associates first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Parametric Portfolio Associates's AVANIR PHARMACEUTICALS, INC CL A position peaked at $580K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Parametric Portfolio Associates's 13F filing for Q1 2015, filed 18 May 2015.